CVX.NYSEChevron CORP

Form 4: Chevron CFO Exercises Options, Sells Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


Chevron's Chief Financial Officer, Eimear P. Bonner, exercised stock options and subsequently sold a portion of the acquired shares under a pre-arranged 10b5-1 trading plan.

Summary

  • Eimear P. Bonner, Chevron's Chief Financial Officer, engaged in multiple transactions involving company common stock.
  • On February 27, 2026, Bonner acquired a total of 28,400 shares (18,800 at $152.35 and 9,600 at $153.22) through the exercise of non-qualified stock options.
  • On the same date, Bonner sold a total of 28,400 shares at weighted-average prices ranging from $184.2776 to $187.1605.
  • On March 2, 2026, Bonner acquired 17,400 shares at $179.08 by exercising non-qualified stock options.
  • Also on March 2, 2026, Bonner sold 17,400 shares at a weighted-average price of $190.6.
  • All sales were executed pursuant to a Rule 10b5-1 trading plan established on November 22, 2025.
  • Following these transactions, Bonner directly beneficially owns 8,427 shares of common stock and indirectly owns 408 shares through a Share Incentive Plan.
  • Remaining unexercised options include 9,400 shares from a 2024 grant and 19,200 shares from a 2025 grant, with future vesting dates.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The transactions are routine executive compensation activities under a pre-arranged plan, neither signaling strong positive nor negative company-specific news.

Positives

  • The transactions were conducted under a Rule 10b5-1 trading plan, indicating pre-scheduled activity and not a reaction to new, material non-public information.
  • The exercise of options indicates the options were 'in the money,' allowing the CFO to realize gains.

Negatives

  • The CFO sold a significant number of shares, reducing direct beneficial ownership.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding Chevron's future performance or strategic direction.

Management Comments

  • The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2025.

Industry Context

StockSavvy.ai notes that executive option exercises and subsequent sales are a routine part of executive compensation and wealth management across the energy sector and broader public markets. Such transactions, especially when conducted under a pre-arranged 10b5-1 plan, are generally not indicative of specific company performance or strategic shifts, but rather personal financial planning.

Comparison to Industry Standards

  • StockSavvy.ai observes that the exercise of stock options and subsequent sale of shares by a Chief Financial Officer is a standard practice for executive compensation realization.
  • This type of transaction is common among executives at major oil and gas companies like ExxonMobil (XOM), Shell (SHEL), and BP (BP), who often receive a significant portion of their compensation in equity.
  • The use of a 10b5-1 plan aligns with best practices for insider trading compliance, similar to those employed by executives at peer companies to avoid accusations of trading on material non-public information.

Stakeholder Impact

  • Shareholders: May perceive a slight negative sentiment from insider selling, though mitigated by the 10b5-1 plan.

Next Steps

  • Future vesting of 9,400 shares from the 2024 option grant on February 10, 2027.
  • Future vesting of 19,200 shares from the 2025 option grant on February 10, 2027, and February 10, 2028.

Key Dates

DateDescription
2023-01-25Grant date for Non-Qualified Stock Option for 17,400 shares.
2024-01-31Vesting date for one-third of the 2023 stock option grant.
2024-02-06Grant date for Non-Qualified Stock Option for 18,800 shares.
2025-01-31Vesting date for one-third of the 2023 stock option grant.
2025-02-04Grant date for Non-Qualified Stock Option for 9,600 shares.
2025-02-10Vesting date for one-third of the 2024 stock option grant.
2025-11-22Date Rule 10b5-1 trading plan was adopted by the reporting person.
2026-01-31Vesting date for one-third of the 2023 stock option grant.
2026-02-10Vesting date for one-third of the 2024 stock option grant and one-third of the 2025 stock option grant.
2026-02-27Transaction date for exercise of 28,400 stock options and sale of 28,400 common shares.
2026-03-02Transaction date for exercise of 17,400 stock options and sale of 17,400 common shares.
2026-03-03Date of filing of the Statement of Changes in Beneficial Ownership.
2027-02-10Future vesting date for one-third of the 2024 stock option grant and one-third of the 2025 stock option grant.
2028-02-10Future vesting date for one-third of the 2025 stock option grant.
2033-01-25Expiration date for 2023 stock option grant.
2034-02-06Expiration date for 2024 stock option grant.
2035-02-04Expiration date for 2025 stock option grant.

Recommendation

hold

The filing details routine insider transactions (option exercises and sales) by Chevron's CFO under a pre-established 10b5-1 plan. These transactions are a normal part of executive compensation and personal financial management and do not provide new material information about the company's operational performance or future prospects. Therefore, the filing itself does not warrant a change in investment recommendation, suggesting a 'hold' position based solely on this disclosure.

Keywords

Chevron, CVX, Insider Trading, Form 4, Stock Options, CFO, Eimear Bonner, 10b5-1 Plan, Share Sale, Executive Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.